428 related articles for article (PubMed ID: 33663486)
1. Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells.
Haiaty S; Rashidi MR; Akbarzadeh M; Bazmani A; Mostafazadeh M; Nikanfar S; Zibaei Z; Rahbarghazi R; Nouri M
BMC Complement Med Ther; 2021 Mar; 21(1):83. PubMed ID: 33663486
[TBL] [Abstract][Full Text] [Related]
2. Tumoricidal properties of thymoquinone on human colorectal adenocarcinoma cells via the modulation of autophagy.
Moulana MS; Haiaty S; Bazmani A; Shabkhizan R; Moslehian MS; Sadeghsoltani F; Mostafazadeh M; Asadi MR; Talebi M; Jafari Z; Morovati MR; Farzaei MH; Rahbarghazi R
BMC Complement Med Ther; 2024 Mar; 24(1):132. PubMed ID: 38532470
[TBL] [Abstract][Full Text] [Related]
3. Targeting the PI3K-Akt-mTOR signaling pathway involved in vasculogenic mimicry promoted by cancer stem cells.
Murai T; Matsuda S
Am J Cancer Res; 2023; 13(11):5039-5046. PubMed ID: 38058805
[TBL] [Abstract][Full Text] [Related]
4. Effects of 5-fluorouracil, thymoquinone, and mammary stem cells' exosomes on
Abdelfattah-Hassan A; Ibrahim D; Saleh AA; Kishawy ATY; Mohamed RHA; Khater SI
Open Vet J; 2024 Jan; 14(1):525-533. PubMed ID: 38633189
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Preventive Effects of Thymoquinone against Breast Cancer: Role of DNMT1.
Kaleem M; Kayali A; Sheikh RA; Kuerban A; Hassan MA; Almalki NAR; Al-Abbasi FA; Anwar F; Omran Z; Alhosin M
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257347
[TBL] [Abstract][Full Text] [Related]
6. The Expression and Functional Significance of Vascular Endothelial-Cadherin, CD44, and Vimentin in Oral Squamous Cell Carcinoma.
Irani S; Dehghan A
J Int Soc Prev Community Dent; 2018; 8(2):110-117. PubMed ID: 29780735
[TBL] [Abstract][Full Text] [Related]
7. Combination Therapy of TRAIL and Thymoquinone Induce Breast Cancer Cell Cytotoxicity-Mediated Apoptosis and Cell Cycle Arrest.
Abdel Salam NM; Abd-Rabou AA; Sharada HM; El Samea GGA; Abdalla MS
Asian Pac J Cancer Prev; 2021 May; 22(5):1513-1521. PubMed ID: 34048180
[TBL] [Abstract][Full Text] [Related]
8. Targeting resistant breast cancer stem cells in a three-dimensional culture model with oleuropein encapsulated in methacrylated alginate microparticles.
Altundag-Erdogan O; Tutar R; Yüce E; Çelebi-Saltik B
Daru; 2024 May; ():. PubMed ID: 38722566
[TBL] [Abstract][Full Text] [Related]
9. Combination of Thymoquinone and Intermittent Fasting as a Treatment for Breast Cancer Implanted in Mice.
Haif SK; Al Kury LT; Talib WH
Plants (Basel); 2023 Dec; 13(1):. PubMed ID: 38202341
[TBL] [Abstract][Full Text] [Related]
10. Exploring MTH1 inhibitory potential of Thymoquinone and Baicalin for therapeutic targeting of breast cancer.
Taiyab A; Choudhury A; Haidar S; Yousuf M; Rathi A; Koul P; Chakrabarty A; Islam A; Shamsi A; Hassan MI
Biomed Pharmacother; 2024 Apr; 173():116332. PubMed ID: 38430630
[TBL] [Abstract][Full Text] [Related]
11. The Inhibition of the FGFR/PI3K/Akt Axis by AZD4547 Disrupts the Proangiogenic Microenvironment and Vasculogenic Mimicry Arising from the Interplay between Endothelial and Triple-Negative Breast Cancer Cells.
Morales-Guadarrama G; Méndez-Pérez EA; García-Quiroz J; Avila E; Ibarra-Sánchez MJ; Esparza-López J; García-Becerra R; Larrea F; Díaz L
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762073
[TBL] [Abstract][Full Text] [Related]
12. Investigation of cellular effects of thymoquinone on glioma cell.
Guler EM; Sisman BH; Kocyigit A; Hatiboglu MA
Toxicol Rep; 2021; 8():162-170. PubMed ID: 33489775
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone Nanoparticle Induces Apoptosis and Cell Migration Retardation through Modulating of SUMOylation Process Genes in Breast Cancer Cell Line.
Sohrabi B; Qadbeigi M; Sabouni F; Hamta A
Iran J Biotechnol; 2024 Jan; 22(1):e3676. PubMed ID: 38827343
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of Thrombospondin-2 modulates tumor vasculogenic mimicry by PI3K/AKT/mTOR signaling pathway.
Huang J; Wang C; Hou Y; Tian Y; Li Y; Zhang H; Zhang L; Li W
Biomed Pharmacother; 2023 Nov; 167():115455. PubMed ID: 37696083
[TBL] [Abstract][Full Text] [Related]
15. Effect of a 630 nm light on vasculogenic mimicry in A549 lung adenocarcinoma cells in vitro.
Lin C; Wang J; Ma Y; Han W; Cao Y; Shao M; Cui S
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103831. PubMed ID: 37806608
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Potential of Thymoquinone-Stabilized Selenium Nanoparticles: In HEC1B Endometrial Cancer Cells Revealing Enhanced Anticancer Efficacy.
Gulbay G; Secme M; Ilhan H
ACS Omega; 2023 Oct; 8(42):39822-39829. PubMed ID: 37901525
[TBL] [Abstract][Full Text] [Related]
17. Thioridazine combined with carboplatin results in synergistic inhibition of triple negative breast cancer by targeting cancer stem cells.
Wang Y; Xia L; Lin J; Gong L; Xia Y; Xu Y; Liu L; Bao J; Zhang C; Chai Y; Li H
Transl Oncol; 2022 Dec; 26():101549. PubMed ID: 36191461
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of thymoquinone on
Karimi Z; Ghaffari M; Ezzati Nazhad Dolatabadi J; Dehghan P
Toxicol Res (Camb); 2019 Nov; 8(6):1050-1056. PubMed ID: 32968481
[TBL] [Abstract][Full Text] [Related]
19. FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer.
Recouvreux MS; Miao J; Gozo MC; Wu J; Walts AE; Karlan BY; Orsulic S
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230774
[TBL] [Abstract][Full Text] [Related]
20. Gigantol Targets Cancer Stem Cells and Destabilizes Tumors via the Suppression of the PI3K/AKT and JAK/STAT Pathways in Ectopic Lung Cancer Xenografts.
Losuwannarak N; Maiuthed A; Kitkumthorn N; Leelahavanichkul A; Roytrakul S; Chanvorachote P
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31861050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
